Guanghua Wan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Guanghua Wan has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Ashwani Rajput
Division of Surgical Oncology, Department of Surgery, University of New Mexico, Albuquerque, NM; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM
2 shared publications D Lidke
Department of Pathology, University of New Mexico, Albuquerque, NM, USA
2 shared publicationsA Mahajan
Department of Pathology, University of New Mexico, Albuquerque, NM, USA
1 shared publicationAshwani Rajput
1 shared publicationC Pehlke
Spatiotemporal Modeling Center, Comprehensive Cancer Center, University of New Mexico , Albuquerque, NM, USA
1 shared publication- Chien-An Andy Hu
Hubei Key Laboratory of Animal Nutrition and Feed Science, Wuhan Polytechnic University, Wuhan 430023, China
1 shared publication
Latest Publications
- Open Access
- 3 December 2015
- Published by Springer Nature in Cell Death & Disease
- Vol. 6 (12) , e2006
Bcl-2 together with PI3K p110α regulates cell morphology and cell migration
- 3 December 2015
- Published by Springer Nature in Cell Death & Disease
- Vol. 6 (12) , e2006
Open AccessBcl-2 together with PI3K p110α regulates cell morphology and cell migration
- Open Access
- 19 October 2015
- Published by Springer Nature in Cell Death Discovery
- Vol. 1 (1) , 15044
The H1047R point mutation in p110 alpha changes the morphology of human colon HCT116 cancer cells
The class IA phosphatidylinositol 3-kinases (PI3K) is involved in controlling changes in cell morphology, which is a highly coordinated cellular event. This event is powered by actin filament polymerization and remodeling. The gain-of-function mutations in the catalytic subunit of p110α of class IA PI3K, which occur in up to one-third of human colorectal cancers (CRCs), are capable of causing dysregulation of cell signaling and thus may result in the alteration in cell morphology and motility and in turn cause cancer metastasis. In vivo studies have demonstrated that cell lines bearing the H1047R point mutation, the most frequent cancer-specific mutation in the kinase domain of p110α, are more metastatic than cells carrying wild-type p110α. In the current study, we show that the H1047R in p110α of PI3K decreases F-actin polymerization, increases the formation of filopodia and significantly changes the cell morphology in HCT116 cancer cells. The anti-apoptotic protein B-cell lymphoma 2 (Bcl-2), which is also involved in actin polymerization and cell migration, is downregulated by the H1047R mutation in p110α. Our data suggest that the H1047R mutation in PI3K is responsible for the rearrangement of the cytoskeleton, alteration in cell morphology and enhancing cell motility, and that Bcl-2 may be involved in the H1047R mutation-mediated morphological changes and increased migratory capability.
- 19 October 2015
- Published by Springer Nature in Cell Death Discovery
- Vol. 1 (1) , 15044
Open AccessThe H1047R point mutation in p110 alpha changes the morphology of human colon HCT116 cancer cells
The class IA phosphatidylinositol 3-kinases (PI3K) is involved in controlling changes in cell morphology, which is a highly coordinated cellular event. This event is powered by actin filament polymerization and remodeling. The gain-of-function mutations in the catalytic subunit of p110α of class IA PI3K, which occur in up to one-third of human colorectal cancers (CRCs), are capable of causing dysregulation of cell signaling and thus may result in the alteration in cell morphology and motility and in turn cause cancer metastasis. In vivo studies have demonstrated that cell lines bearing the H1047R point mutation, the most frequent cancer-specific mutation in the kinase domain of p110α, are more metastatic than cells carrying wild-type p110α. In the current study, we show that the H1047R in p110α of PI3K decreases F-actin polymerization, increases the formation of filopodia and significantly changes the cell morphology in HCT116 cancer cells. The anti-apoptotic protein B-cell lymphoma 2 (Bcl-2), which is also involved in actin polymerization and cell migration, is downregulated by the H1047R mutation in p110α. Our data suggest that the H1047R mutation in PI3K is responsible for the rearrangement of the cytoskeleton, alteration in cell morphology and enhancing cell motility, and that Bcl-2 may be involved in the H1047R mutation-mediated morphological changes and increased migratory capability.
- Open Access
- 16 November 2008
- Published by Taylor & Francis in Autophagy
- Vol. 4 (8) , 1079-1082
ApoL1, a BH3-only lipid-binding protein, induces autophagic cell death
We recently reported the identification and characterization of a novel BH3-only pro-death protein, apolipoprotein L1 (ApoL1), that, when overexpressed, induces autophagic cell death (ACD) in a var...
- 16 November 2008
- Published by Taylor & Francis in Autophagy
- Vol. 4 (8) , 1079-1082
Open AccessApoL1, a BH3-only lipid-binding protein, induces autophagic cell death
We recently reported the identification and characterization of a novel BH3-only pro-death protein, apolipoprotein L1 (ApoL1), that, when overexpressed, induces autophagic cell death (ACD) in a var...